{"id":"https://openalex.org/W7214630780","doi":"https://doi.org/10.64898/2026.09.24.754209","title":"Spatial immune profiling reveals lymphocyte confinement to myeloid\u2013mesenchymal niches and heterogeneous therapeutic T-cell opportunity in pediatric ependymoma","display_name":"Spatial immune profiling reveals lymphocyte confinement to myeloid\u2013mesenchymal niches and heterogeneous therapeutic T-cell opportunity in pediatric ependymoma","publication_year":2026,"publication_date":"2026-09-28","ids":{"openalex":"https://openalex.org/W7214630780","doi":"https://doi.org/10.64898/2026.09.24.754209"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.24.754209","doi":"https://doi.org/10.64898/2026.09.24.754209","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.24.754209","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/28/2026.09.24.754209.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/28/2026.09.24.754209.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082440920","display_name":"Patrick Truong","orcid":"https://orcid.org/0000-0001-9242-4107","observed_orcids":["https://orcid.org/0000-0001-9242-4107"]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I86987016","display_name":"KTH Royal Institute of Technology","ror":"https://ror.org/026vcq606","country_code":"SE","type":"education","lineage":["https://openalex.org/I86987016"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Patrick Truong","raw_affiliation_strings":["Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0001-9242-4107","affiliations":[{"raw_affiliation_string":"Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I86987016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048570684","display_name":"Reza Mirzazadeh","orcid":"https://orcid.org/0000-0003-0554-080X","observed_orcids":["https://orcid.org/0000-0003-0554-080X"]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I86987016","display_name":"KTH Royal Institute of Technology","ror":"https://ror.org/026vcq606","country_code":"SE","type":"education","lineage":["https://openalex.org/I86987016"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Reza Mirzazadeh","raw_affiliation_strings":["Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0003-0554-080X","affiliations":[{"raw_affiliation_string":"Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I86987016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054656710","display_name":"Joakim Lundeberg","orcid":"https://orcid.org/0000-0003-4313-1601","observed_orcids":["https://orcid.org/0000-0003-4313-1601"]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I86987016","display_name":"KTH Royal Institute of Technology","ror":"https://ror.org/026vcq606","country_code":"SE","type":"education","lineage":["https://openalex.org/I86987016"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Joakim Lundeberg","raw_affiliation_strings":["Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0003-4313-1601","affiliations":[{"raw_affiliation_string":"Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I86987016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021905275","display_name":"Klas Blomgren","orcid":"https://orcid.org/0000-0002-0476-7271","observed_orcids":["https://orcid.org/0000-0002-0476-7271"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Klas Blomgren","raw_affiliation_strings":["Department of Women\u2019s and Children\u2019s Health (KBH), Karolinska Institutet, Stockholm, Sweden","Pediatric Oncology, Karolinska University Hospital, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0002-0476-7271","affiliations":[{"raw_affiliation_string":"Department of Women\u2019s and Children\u2019s Health (KBH), Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Pediatric Oncology, Karolinska University Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020603013","display_name":"Lola Boutin","orcid":"https://orcid.org/0000-0001-7928-6731","observed_orcids":["https://orcid.org/0000-0001-7928-6731"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Lola Boutin","raw_affiliation_strings":["Department of Women\u2019s and Children\u2019s Health (KBH), Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":"https://orcid.org/0000-0001-7928-6731","affiliations":[{"raw_affiliation_string":"Department of Women\u2019s and Children\u2019s Health (KBH), Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5020603013"],"corresponding_institution_ids":["https://openalex.org/I28166907"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5737000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5737000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11289","display_name":"Single-cell and spatial transcriptomics","score":0.2605000138282776,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.13289999961853027,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-ependymoma","display_name":"pediatric ependymoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.8740000128746033},{"id":"https://openalex.org/keywords/spatial-immune-profiling","display_name":"spatial immune profiling","score":0.7720000147819519},{"id":"https://openalex.org/keywords/alpha-beta-t-cells","display_name":"alpha beta T cells","score":0.777999997138977},{"id":"https://openalex.org/keywords/gamma-delta-t-cells","display_name":"\u03b3\u03b4 T cells","score":0.996999979019165},{"id":"https://openalex.org/keywords/ligand-receptor-interactions","display_name":"ligand-receptor interactions","score":0.6940000057220459},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.5920000076293945},{"id":"https://openalex.org/keywords/pediatric-brain-tumors","display_name":"pediatric brain tumors","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C2781432949","wikidata":"https://www.wikidata.org/wiki/Q1346753","display_name":"Ependymoma","level":2,"score":0.7631000280380249},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7246000170707703},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7008000016212463},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6904000043869019},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4528000056743622},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42289999127388},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.3950999975204468},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3871000111103058},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3833000063896179},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.37389999628067017},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.34929999709129333},{"id":"https://openalex.org/C2779130545","wikidata":"https://www.wikidata.org/wiki/Q233309","display_name":"Brain tumor","level":2,"score":0.3384999930858612},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.3190999925136566},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3107999861240387},{"id":"https://openalex.org/C2777702733","wikidata":"https://www.wikidata.org/wiki/Q1356761","display_name":"Immune tolerance","level":3,"score":0.28610000014305115},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2858999967575073},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2831999957561493},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.28200000524520874},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.27480000257492065},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25859999656677246}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.24.754209","doi":"https://doi.org/10.64898/2026.09.24.754209","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.24.754209","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/28/2026.09.24.754209.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.24.754209","doi":"https://doi.org/10.64898/2026.09.24.754209","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.24.754209","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/28/2026.09.24.754209.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320313607","display_name":"Swedish Cancer Foundation","ror":null},{"id":"https://openalex.org/F4320321491","display_name":"Cancerfonden","ror":"https://ror.org/0527jb766"},{"id":"https://openalex.org/F4320322315","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691"},{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"},{"id":"https://openalex.org/F4320323766","display_name":"Barncancerfonden","ror":"https://ror.org/05072yv34"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214630780.pdf","grobid_xml":"https://content.openalex.org/works/W7214630780.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W1949037014","https://openalex.org/W2027729143","https://openalex.org/W2078786084","https://openalex.org/W2127043123","https://openalex.org/W2129504986","https://openalex.org/W2306651097","https://openalex.org/W2308211810","https://openalex.org/W2556719690","https://openalex.org/W2586932252","https://openalex.org/W2789869568","https://openalex.org/W2889354357","https://openalex.org/W2942610007","https://openalex.org/W2949274697","https://openalex.org/W2971477701","https://openalex.org/W2992151131","https://openalex.org/W3007935255","https://openalex.org/W3082278712","https://openalex.org/W3132661792","https://openalex.org/W3134443156","https://openalex.org/W3174072032","https://openalex.org/W3207648464","https://openalex.org/W3215629464","https://openalex.org/W4220890889","https://openalex.org/W4283755738","https://openalex.org/W4304114149","https://openalex.org/W4310534762","https://openalex.org/W4378908509","https://openalex.org/W4385407813","https://openalex.org/W4385686863","https://openalex.org/W4386527000","https://openalex.org/W4387692665","https://openalex.org/W4387865405","https://openalex.org/W4388762227","https://openalex.org/W4391167454","https://openalex.org/W4400428064","https://openalex.org/W4401344660","https://openalex.org/W4401486900","https://openalex.org/W4401992111","https://openalex.org/W4404928895","https://openalex.org/W4405917544","https://openalex.org/W4406446406","https://openalex.org/W4407126498","https://openalex.org/W4409236500","https://openalex.org/W4409878044","https://openalex.org/W4414056195","https://openalex.org/W4416453132","https://openalex.org/W4417487617","https://openalex.org/W7166813464"],"related_works":["https://openalex.org/W4399787496","https://openalex.org/W4304114149","https://openalex.org/W3202206820","https://openalex.org/W4220771346","https://openalex.org/W4281635931","https://openalex.org/W3111945985","https://openalex.org/W4417487617","https://openalex.org/W3170347517","https://openalex.org/W4409500955","https://openalex.org/W4385686863"],"abstract_inverted_index":{"Abstract":[0],"Pediatric":[1],"posterior":[2],"fossa":[3],"group":[4],"A":[5],"(PFA)":[6],"ependymoma":[7,56,195],"is":[8],"an":[9],"aggressive,":[10],"chemo-resistant":[11],"brain":[12],"tumor":[13,124,205],"with":[14,126,207],"a":[15,48,66,198,204,216],"poor":[16],"10-year":[17],"overall":[18],"survival":[19],"and":[20,34,80,105,122,143,150,154,165,184,214,224],"no":[21],"therapeutic":[22,35],"options":[23],"at":[24],"relapse.":[25],"Although":[26],"conventionally":[27],"classified":[28,99],"as":[29,197,203],"immune-cold,":[30],"the":[31,171,175],"spatial":[32,61],"organization":[33],"relevance":[36],"of":[37,53,93,178],"its":[38],"rare":[39],"immune":[40,51,200,212,222],"infiltrates":[41],"remain":[42],"poorly":[43],"characterized.":[44],"Here,":[45],"we":[46],"present":[47],"spatially":[49,151,183,208],"resolved":[50],"analysis":[52,133],"14":[54,94],"PFA":[55,194],"sections":[57,95],"using":[58],"published":[59],"Visium":[60],"transcriptomics":[62],"data":[63],"analyzed":[64],"through":[65],"multi-stage":[67],"immune-focused":[68],"computational":[69,218],"framework":[70],"combining":[71],"reference-guided":[72],"deconvolution,":[73],"functional":[74],"lymphocyte":[75],"state":[76],"scoring,":[77],"ligand\u2013receptor":[78,132],"inference,":[79],"\u03b1\u03b2/\u03b3\u03b4":[81],"T":[82,156,225],"cell":[83,157,226],"immunotherapy":[84],"opportunity":[85,146],"scoring.":[86],"Lymphocyte-associated":[87],"hotspots":[88,116],"were":[89,101,117,182],"identified":[90,134],"in":[91,170,229],"6":[92],"and,":[96],"among":[97],"confidently":[98],"hotspots,":[100],"dominated":[102],"by":[103],"inflammatory-associated":[104],"retention-associated":[106],"transcriptional":[107],"states":[108],"rather":[109],"than":[110],"cytotoxic":[111],"or":[112],"exhausted":[113],"programs.":[114],"These":[115],"preferentially":[118],"confined":[119],"to":[120],"myeloid-":[121],"mesenchymal-rich":[123],"zones":[125],"near-complete":[127],"exclusion":[128],"from":[129,187],"epithelial":[130],"regions;":[131],"four":[135],"candidate":[136],"restriction":[137],"axes":[138],"(SPP1\u2013CD44,":[139],"FN1\u2013integrin,":[140],"collagen":[141],"VI\u2013integrin,":[142],"APP\u2013CD74).":[144],"Immunotherapy":[145],"scoring":[147],"revealed":[148],"heterogeneous":[149],"compartmentalized":[152],"\u03b1\u03b2":[153],"\u03b3\u03b4":[155,179],"recognition":[158,181],"landscapes":[159],"across":[160],"sections:":[161],"\u03b1\u03b2T":[162],"ligand":[163],"availability":[164],"immunosuppressive":[166],"tone":[167],"both":[168],"rose":[169],"mesenchymal":[172],"compartment,":[173],"while":[174],"two":[176],"components":[177],"phosphoantigen-mediated":[180],"transcriptionally":[185],"dissociated":[186],"one":[188],"another.":[189],"Together,":[190],"these":[191],"findings":[192],"reframe":[193],"not":[196],"monolithic":[199],"desert":[201],"but":[202],"type":[206],"compartmentalized,":[209],"mechanistically":[210],"tractable":[211],"niches,":[213],"provide":[215],"generalizable":[217],"strategy":[219],"for":[220],"mapping":[221],"architecture":[223],"therapy":[227],"susceptibility":[228],"low-infiltrated":[230],"pediatric":[231],"CNS":[232],"tumors.":[233]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-09-29T00:00:00"}